Significant international leadership and experience in Research and Drug Development including Medical/Clinical Strategy and Research, Project Management, Portfolio and Planning, and Preclinical as well as Business Development over the last 30 years. Creative, enthusiastic and innovative in overall strategic thinking including Research and Development (small molecules and complex biologics), patients, payers and marketing/business aspects. Led interdisciplinary/ international teams in different Therapeutic Areas through all phases of development including registration in the EU, USA and Japan within six different Pharmaceutical companies, Rhône-Poulenc, Rhône-Poulenc Rorer, Aventis, Pierre Fabre, Ipsen and Algotherapeutix.